Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SNDX will decline by -11.53% over the next 2 Weeks and hit $18.25 by Wednesday, May 13, 2026. In that time frame, SNDX's share price is expected to range between $17.45 and $19.10.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 13, 2026 | 17.45 | 18.25 | 19.10 |
| May 12, 2026 | 17.73 | 18.56 | 19.37 |
| May 11, 2026 | 17.63 | 18.47 | 19.26 |
| May 8, 2026 | 18.08 | 18.91 | 19.72 |
| May 7, 2026 | 18.61 | 19.37 | 20.12 |
| May 6, 2026 | 18.71 | 19.48 | 20.31 |
| May 5, 2026 | 19.03 | 19.79 | 20.55 |
| May 4, 2026 | 18.92 | 19.70 | 20.49 |
| May 1, 2026 | 19.34 | 20.14 | 20.90 |
| Apr 30, 2026 | 19.84 | 20.60 | 21.44 |
SNDX shares rose +3.97% in Thursday, April 30, 2026's trading session, rising from a previous close of $20.63 to move at $21.45. The stock demonstrated notable intraday movement (see SNDX's key stats for a full breakdown), fluctuating between $20.70 and $21.45, a +3.64% trading range. While recent weeks have seen some volatility, SNDX has managed to secure a -12.20% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.42M shares changing hands, 1.35M more than the previous session. This amounted to $52.00M in total market activity.
Will SNDX Continue Its Downward Trend?
According to analyst ratings and projections for SNDX, Syndax Pharmaceuticals, Inc. shares are anticipated to decrease by -12.30%, potentially reaching $19.10 per share by May 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for SNDX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the SNDX stock forecast, now is not the best time to buy SNDX stock because its current trading price is +17.53% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on SNDX covering social and institutional perspectives.
SNDX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SNDX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.56% to 42.79%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.80%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.15%, maintains a neutral outlook for the long term. Insights into SNDX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Syndax Pharmaceuticals Short-Term Forecasts
SNDX Forecast For Next 5 Days
Our algorithm anticipates Syndax Pharmaceuticals (SNDX) stock could hit $22.16 by May 07, 2026. This represents a +3.31% fall from today's price, following a -2.36% change over the past five days.
SNDX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Syndax Pharmaceuticals, Inc. (SNDX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $21.54, which would mean a +0.42% increase from the current price of $21.45. Projections for this period range from a high of $24.03 to a low of $19.25.
SNDX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Syndax Pharmaceuticals's price over the next three months point to a drop. SNDX stock is expected to peak at $24.23 on Jun 10, 2026 after potentially dipping to $18.83 on May 15, 2026. On average, SNDX is likely to trade around $21.44 in the coming 90 days.
Syndax Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Syndax Pharmaceuticals (SNDX) is expected to trade between $16.08 and $26.39 throughout 2026. This would result in an average price of $21.04, potentially offering investors a -1.91% return from current levels.
Syndax Pharmaceuticals, Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Syndax Pharmaceuticals, Inc. (SNDX) is positioned to show a strong performance in April 2026. The price is predicted to move between $19.17 and $22.37, settling at an average of $20.71. This could translate to a -3.45% loss.
May 2026
Based on current market signals, Syndax Pharmaceuticals, Inc. is projected to trend may 2026. We forecast a trading range from $18.83 to $23.40, with a likely average price of $20.91. Investors could expect a potential return of -2.52%.
June 2026
Our predictive algorithms indicate Syndax Pharmaceuticals, Inc. stock may see a shift in June 2026. The expected range spans $20.10–$24.23, with an average target of $22.15. This represents a positive outlook and a possible gain of +3.26%.
July 2026
Analyzing established trends, Syndax Pharmaceuticals, Inc. looks set to move in July 2026. Projections place the stock between $19.20 and $23.38, averaging around $21.27. This suggests a -0.84% loss from current levels.
August 2026
Market indicators suggest Syndax Pharmaceuticals, Inc. could experience notable changes during August 2026. Prices could fluctuate within $18.54 to $22.89, with a midpoint forecast of $20.87. The stock might deliver a -2.70% loss.
September 2026
Forecasting for September 2026, models estimate that Syndax Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $18.49 and $22.72, averaging $20.46. This signals a cautious trajectory with potential returns around -4.62%.
October 2026
According to our latest forecast models, Syndax Pharmaceuticals, Inc. (SNDX) is positioned to show a strong performance in October 2026. The price is predicted to move between $16.08 and $23.09, settling at an average of $20.40. This could translate to a -4.90% loss.
November 2026
Based on current market signals, Syndax Pharmaceuticals, Inc. is projected to trend november 2026. We forecast a trading range from $19.55 to $26.39, with a likely average price of $21.70. Investors could expect a potential return of +1.17%.
December 2026
Our predictive algorithms indicate Syndax Pharmaceuticals, Inc. stock may see a shift in December 2026. The expected range spans $18.62–$22.66, with an average target of $20.63. This represents a cautious outlook and a possible loss of -3.82%.
January 2027
Analyzing established trends, Syndax Pharmaceuticals, Inc. looks set to move in January 2027. Projections place the stock between $18.15 and $22.30, averaging around $20.25. This suggests a -5.59% loss from current levels.
February 2027
Market indicators suggest Syndax Pharmaceuticals, Inc. could experience notable changes during February 2027. Prices could fluctuate within $17.90 to $22.10, with a midpoint forecast of $19.89. The stock might deliver a -7.27% loss.
March 2027
Forecasting for March 2027, models estimate that Syndax Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $17.70 and $22.56, averaging $19.97. This signals a cautious trajectory with potential returns around -6.90%.
April 2027
According to our latest forecast models, Syndax Pharmaceuticals, Inc. (SNDX) is positioned to show a strong performance in April 2027. The price is predicted to move between $18.75 and $23.17, settling at an average of $20.98. This could translate to a -2.19% loss.
SNDX's history of dividends and stock splits also plays a role in long-term investor confidence.

